MedPath

AICHI CANCER CENTER

πŸ‡―πŸ‡΅Japan
Ownership
-
Employees
-
Market Cap
-
Website

Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or Hypopharynx

Phase 2
Completed
Conditions
Head and Neck Cancer
First Posted Date
2005-10-21
Last Posted Date
2013-03-26
Lead Sponsor
Aichi Cancer Center
Target Recruit Count
50
Registration Number
NCT00243113
Locations
πŸ‡―πŸ‡΅

Chiba University, Chiba City, Chiba, Japan

πŸ‡―πŸ‡΅

Aichi Cancer Center, Nagoya, Aichi, Japan

πŸ‡―πŸ‡΅

Hirosaki University, School of Medicine, Hirosaki, Aomori, Japan

and more 6 locations

Fluorouracil, Cisplatin, and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Nasopharyngeal Cancer

Phase 2
Conditions
Head and Neck Cancer
First Posted Date
2004-10-08
Last Posted Date
2013-05-15
Lead Sponsor
Aichi Cancer Center
Target Recruit Count
90
Registration Number
NCT00093665
Locations
πŸ‡―πŸ‡΅

Kanazawa University, Kanazawa, Japan

πŸ‡―πŸ‡΅

Nara Medical University Cancer Center, Nara, Japan

πŸ‡―πŸ‡΅

Graduate School of Medical Science at the University of Ryukyu, Okinawa, Japan

and more 4 locations
Β© Copyright 2025. All Rights Reserved by MedPath